We would like to thank the author for their comments. We would be happy to provide some further explanation regarding the questions and comments regarding our paper.1 A correction has now been issued for points (2) and (3).

(1) In regards to the cost discrepancy of andexanet alfa, we cited and referenced the correct cost of the medication as of 2019, at the time of the study. We do …